The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.
Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, Dugas A. · 2016
Read The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. by Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, Dugas A. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4947938.txt.
Introduction
Eili Y. Klein and six co-authors measure how often bacteria coinfect people who have influenza. Their systematic review and meta-analysis appeared in Influenza and Other Respiratory Viruses in 2016. Bacterial partners are a major cause of illness and death in flu, yet counts of coinfection were scattered. The team searched six databases for studies where every patient had lab confirmed flu and was tested for a panel of bacteria.
Twenty-seven studies with 3,215 participants qualified. Reported coinfection rates ranged wildly, from 2 percent to 65 percent, and no study trait explained the spread. Streptococcus pneumoniae led the coinfecting species at 35 percent, followed by Staphylococcus aureus at 28 percent. The authors advise doctors to expect coinfection in hospitalized flu patients and to take bacterial cultures. They also warn that starting antibiotics blindly risks overuse and may miss resistant strains.
Catalog record
| CREATOR | Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, Dugas A. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis By Eili Y Klein, Bradley Monteforte, Alisha Gupta, Wendi Jiang, Larissa May, Yu‐Hsiang Hsieh, Andrea Dugas Published in: Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12398 ABSTRACT Abstract Aim Coinfecting bacterial pathogens are a major cause of morbidity and mortality in influenza. However, there remains a paucity of literature on the magnitude of coinfection in influenza patients. Method A systematic search of MeSH, Cochrane Library, Web of Science, SCOPUS, EMBASE, and PubMed was performed. Studies of humans in which all individuals had laboratory confirmed influenza, and all individuals were tested for an array of common bacterial species, met inclusion criteria. Results Twenty‐seven studies including 3215 participants met all inclusion criteria. Common etiologies were defined from a subset of eight articles. There was high heterogeneity in the results (I 2 = 95%), with reported coinfection rates ranging from 2% to 65%. Although only a subset of papers were responsible for observed heterogeneity, subanalyses and meta‐regression analysis found no study characteristic that was significantly associated with coinfection. The most common coinfecting species were Streptococcus pneumoniae and Staphylococcus aureus, which accounted for 35% (95% CI, 14%–56%) and 28% (95% CI, 16%–40%) of infections, respectively; a wide range of other pathogens caused the remaining infections. An assessment of bias suggested that lack of small‐study publications may have biased the results. Conclusions The frequency of coinfection in the published studies included in this review suggests that although providers should consider possible bacterial coinfection in all patients hospitalized with influenza, they should not assume all patients are coinfected and be sure to properly treat underlying viral processes. Further, high heterogeneity suggests additional large‐scale studies are needed to better understand the etiology of influenza bacterial coinfection. Keywords: antibiotic resistance, bacterial coinfection, influenza, meta‐analysis, MRSA, Streptococcus Pneumoniae WHAT THIS ADDS TO EXISTING LITERATURE Clinical treatment of influenza presents difficulties because of significant uncertainty regarding the probability of bacterial coinfection. Despite this uncertainty, the frequency of overall coinfection in influenza patients is still poorly characterized. This meta‐analysis increases understanding of the likelihood that patients hospitalized with influenza also have a bacterial coinfection; however, the variability in results suggests that physicians should ensure that appropriate cultures are taken to minimize the overuse of antibiotics. INTRODUCTION Influenza causes widespread annual epidemics infecting up to 20% of the population and resulting in significant morbidity and mortality.1 Coinfecting bacterial pathogens are a major cause of that morbidity and mortality and are associated with both pandemic and seasonal influenza virus illness.2 Lung tissue samples from the 1918 influenza pandemic suggest that the majority of the estimated 20–60 million deaths were from bacterial infections rather than from direct effects of the virus.3 In seasonal epidemics, influenza bacterial coinfection is associated with increases in hospital admissions,4, 5 more severe symptoms,6 and increases in mortality.7 Viral damage to the epithelial lining of the respiratory tract is believed to facilitate establishment of bacterial infections.8, 9, 10 However, other factors, such as changes in airway function, up‐regulation and exposure of receptors, dampening of the immune response, or enhancement of inflammation may also play a role.11 Clinically, it can be difficult to identify influenza patients experiencing bacterial coinfections, given the substantial symptom overlap of influenza and bacterial infections. Identification of coinfected patients and coinfecting pathogen enables clinicians to initiate appropriate antibiotic therapy and improve patient outcomes.12 While prior studies have examined the frequency of select bacterial species in influenza cases,13, 14 particularly the presence of methicillin‐resistant S. aureus (MRSA),15, 16, 17, 18 the frequency of overall coinfection in influenza patients is still poorly characterized. We undertook a systematic review to determine the frequency of bacterial coinfections in patients with laboratory confirmed influenza and to identify the most common coinfecting bacterial species. METHODS We conducted a systematic review, which is reported in accordance with PRISMA guidelines,19 to determine the frequency of bacterial coinfection among individuals with laboratory confirmed influenza. Inclusion was restricted to studies of humans in which all individuals had laboratory confirmed influenza, and all individuals were tested for an array of common bacterial species. Studies reanalyzing prior published data were excluded. There were no limitations based on participant age or the location of participant recruitment (i.e., community, outpatient, hospital). Coinfection was assumed to be any acute bacterial infection identified in respiratory secretions, sputum, or sterile site (e.g., bacteremia). We restricted results to publications in English published after January 1982. To avoid analyses of historic samples, particularly related to the influenza pandemic of 1968, studies using data collected prior to 1972 were excluded. Case reports, defined as studies with a sample size of fewer than 10 individuals, were excluded, but no other limitations based on study design were imposed. Literature search We performed a systematic search of MeSH, Cochrane Library, Web of Science, SCOPUS, EMBASE, and PubMed for publications in August 2014. The search terms included influenza, bacterial infection, bacterial coinfection, bacterial pathogens, bacteremia, bacterial–viral infection, coinfection, secondary infection, mixed infection, concomitant infection, H1N1, swine influenza, bird flu, gripe, pandemic influenza, seasonal influenza, influenza virus A H1N1, and avian influenza. The complete search strategy, which was completed in consultation with a research librarian, is detailed in Table S1. Selection of studies Two authors (BM, AG) independently screened the title and abstract of all the search‐returned publications to determine whether they met study criteria. The full text of all studies meeting the criteria and those for which a conclusion could not be made were reviewed independently by the two authors. Disagreements were resolved through consultation with a third party. Data extraction A structured data extraction form was used to collect data elements of each study into a Microsoft Excel worksheet. Two authors (BM, AG) extracted study data from all included publications independently, and results were then compared. Differences were resolved by consensus. Information extracted included: study design (i.e., prospective, retrospective), location of the study, study size, year of enrollment, study enrollment setting (i.e., intensive care unit [ICU], hospital, or emergency department [ED]), influenza strain (A, A pH1N1, B, all), participant age, bacterial collection method (sputum, blood, bronchial alveolar lavage [BAL]), method of bacterial detection (stain, culture, polymerase chain reaction [PCR], antibody), bacterial species evaluated, and bacterial species identified. In cases where only a percentage or subject number was published, its counterpart was calculated for analysis in the current review. Sources of data were carefully reviewed by BM, AG, EK, and studies reporting already included data were excluded (the study with the earlier publication date was considered the primary study, and all others excluded). Assessment of bias The potential bias of each study was assessed using the Quality Assessment Tool for Quantitative Studies developed by the National Collaborating Centre for Methods and Tools.20 This tool was selected for its comprehensive ability to assess the methodological quality of non‐randomized studies and has shown good reliability and validity.21, 22 A 3‐point scale was used for the following criteria: selection bias, study design, confounders, blinding, data collection methods, and study withdrawals. A global rating of “strong” was awarded for 4 “strong” ratings and no “weak” ratings, “moderate” for less than four “strong” and one “weak,” and “weak” for two or more “weak” ratings. Each study was independently evaluated by two authors, and discrepancies regarding